Browse Items (33 total)
- Tags: pharmacologic intervention
Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial
Tags: 1982, Adolescent, Adult, amantadine, Amantadine/therapeutic use, Antiparkinson Agents/therapeutic use, Benserazide/therapeutic use, Clinical Neurology and Neurosurgery, Drug Combinations/therapeutic use, Humans, Levodopa/therapeutic use, Lipidoses/drug therapy, madopar, NCL3, orfenadrine, pharmacologic intervention, Psychoses Substance-Induced/etiology, Syndrome, tone and motor problems, van der Zee H J, van Nieuwenhuizen O, Zweije-Hofman I L
A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia
Tags: 2012, ataxia, ataxia telangectasia, betamethasone, Betti G, Brusco A, Buoni S, Chessa L, Finocchi A, Fois A, Hayek J, Kelly C, Leuzzi V, Martino S, Micheli R, Misiani F, Movement Disorders, pharmacologic intervention, Pietrogrande M C, Plebani A, Rossi L N, Salvucci S, Soresina A, tone and motor problems, Zannolli R
Melatonin treatment for sleep disorders in children with neurodevelopmental disorders: an observational study
Tags: 2002, Adolescent, Child, Child Preschool, Davies P, Developmental Disabilities, Developmental Disabilities/complications, Developmental Medicine and Child Neurology, Dose-Response Relationship Drug, Epilepsy, Epilepsy/complications, Female, Humans, Infant, Lennox-Gastaut syndrome, Leukodystrophy, Male, Medical Records, melatonin, Melatonin/therapeutic use, MPSII, MPSIII, Nervous System Diseases, Nervous System Diseases/complications, Outpatients, pharmacologic intervention, Q3 Scoping Review Results, Ross C, Sex Factors, Sleep Disorders/complications/drug therapy, sleep disturbance/disorders, Sleep Wake Disorders, Vision Disorders, Vision Disorders/complications, Whitehouse W
Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment
Tags: 2004, Antioxidants/therapeutic use, Appleton R E, Brain/physiopathology, Child, Developmental Disabilities/drug therapy/epidemiology/physiopathology, Developmental Medicine and Child Neurology, Humans, melatonin, Melatonin/therapeutic use, pharmacologic intervention, Phillips L, Rett syndrome, sleep disturbance/disorders, Sleep Wake Disorders/epidemiology, Wakefulness/physiology
Use of melatonin to treat sleep disorders in tuberous sclerosis
Serotonergic approaches to the modification of behavior in the Lesch-Nyhan syndrome
Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate
Tags: 0 (Antiparkinson Agents), 2013, Adolescent, amantadine sulfate, Amantadine/tu [Therapeutic Use], Antiparkinson Agents/Antiparkinson [Therapeutic Use], ataxia telangiectasia, Ataxia Telangiectasia/co [Complications], Ben-Zeev B, BF4C9Z1J53 (Amantadine), Child, Disability, Evaluation, Hassin-Baer S, Humans, Journal of Child Neurology, Lerman S F, Levi Y B, Movement Disorders/dt [Drug Therapy], Movement Disorders/et [Etiology], Neurologic Examination, Nissenkorn A, pharmacologic intervention, Preschool, Prospective Studies, Severity Of Illness Index, tone and motor problems, Tzadok M
Botulinum Toxin Type A for the Treatment of Equinus Deformity in Patients With Mucopolysaccharidosis Type II
Tags: 2012, botulinum toxin type A, cerebral-palsy, Children, Disease, equinus deformity, Gautschi M, Grunt S, Hunter syndrome, hunter-syndrome, II, Journal of Child Neurology, Management, MPSII, mucopolysaccharidosis type, Nava E, Neurosciences & Neurology, Nuoffer J M, Pediatrics, pharmacologic intervention, physical intervention, Physical Therapy, Recommendations, serial casting, skeletal-muscle, tone and motor problems, Weber P
Naltrexone therapy of apnea in children with elevated cerebrospinal fluid beta-endorphin
Tags: 1990, Annals Of Neurology, beta-Endorphin/cerebrospinal fluid, Biomarkers of Pain, Brase D A, breathing difficulties, Child, Child Preschool, Dewey W L, Female, Humans, Infant, Infant Newborn, Leigh Disease/cerebrospinal fluid, Leigh syndrome, Male, Morris D L, Myer E C, Naltrexone, Naltrexone/therapeutic use, oral naltrexone, pharmacologic intervention, Prospective Studies, Sleep apnea, Sleep Apnea Syndromes/cerebrospinal fluid/drug therapy, Zimmerman A W
Supplementation with carnitine reduces the severity of constipation: A retrospective study of patients with severe motor and intellectual disabilities
Tags: 102767-28-2 (levetiracetam), 1069-66-5 (valproic acid), 1309-48-4 (magnesium oxide), 1317-74-4 (magnesium oxide), 14093-02-8 (iron), 14378-32-6 (zinc), 146-22-5 (nitrazepam), 1622-61-3 (clonazepam), 2017, 22316-47-8 (clobazam), 298-46-4 (carbamazepine), 461-06-3 (carnitine), 50-06-6 (phenobarbital), 53858-86-9 (iron), 541-15-1 (carnitine), 56-99-5 (carnitine), 57-30-7 (phenobarbital), 57-88-5 (cholesterol), 59-30-3 (folic acid), 6484-89-5 (folic acid), 68291-97-4 (zonisamide), 7439-89-6 (iron), 7440-66-6 (zinc), 7782-49-2 (selenium), 8028-68-0 (phenobarbital), 8047-84-5 (carbamazepine), 84057-84-1 (lamotrigine), 99-66-1 (valproic acid), acute brain disease, Adult, albumin, albumin blood level, anticonvulsant therapy, Aomatsu T, Article, bacterial meningitis, bed rest, body mass, brain infarction, carbamazepine/dt [Drug Therapy], carnitine, carnitine deficiency, carnitine deficiency/dt [Drug Therapy], carnitine/dt [Drug Therapy], Cerebral Palsy, Child, cholesterol blood level, cholesterol/ec [Endogenous Compound], Clinical Article, Clinical Trial, clobazam/dt [Drug Therapy], clonazepam/dt [Drug Therapy], Constipation, constipation/dt [Drug Therapy], constipation/pc [Prevention], Controlled Study, copper blood level, cupric ion/ec [Endogenous Compound], diet supplementation, Disease Severity, Endogenous Compound, enema/dt [Drug Therapy], enteric feeding, epilepsy/dt [Drug Therapy], Female, folic acid, folic acid blood level, folic acid/ec [Endogenous Compound], Gene Expression, groups by age, Hospital, Human, Human Tissue, infantile spasm, Inoue K, Intellectual Impairment, iron blood level, iron/ec [Endogenous Compound], Journal of Clinical Biochemistry and Nutrition, lamotrigine/dt [Drug Therapy], levetiracetam/dt [Drug Therapy], magnesium oxide/dt [Drug Therapy], Male, Medical Record Review, Middle Aged, motor dysfunction, Murata S, NCL3, neuronal ceroid lipofuscinosis, nitrazepam/dt [Drug Therapy], Pelizaeus Merzbacher disease, Pelizaeus- Merzbacher disease, periventricular leukomalacia, pharmacologic intervention, phenobarbital/dt [Drug Therapy], prealbumin, prealbumin/ec [Endogenous Compound], Preschool Child, Retrospective Study, School Child, selenium blood level, selenium/ec [Endogenous Compound], sex difference, Tamai H, trace element, Tuberous Sclerosis, valproic acid, valproic acid/dt [Drug Therapy], West syndrome, Yoden A, Young Adult, zinc/ec [Endogenous Compound], zonisamide/dt [Drug Therapy]
Feed-induced Dystonias in Children with Severe Central Nervous System Disorders
Tags: 1134-47-0 (baclofen), 2017, acquired brain injury, Adolescent, Article, Baclofen/dt [drug Therapy], baclofen/tl [Intrathecal Drug Administration], Campbell D I, Case Study, central nervous system disease, Cerebral Palsy, Child, Clinical Article, Constipation, Dystonia, dystonia/dt [Drug Therapy], feed induced dystonia, feed induced dystonia/dt [Drug Therapy], feeding difficulties, Female, Gastroesophageal Reflux, Gastroscopy, GERD, Human, Hydrocephalus, Hyperglycinemia, Infant, infantile spasm, intestinal dysmotility, intestine motility, Intestine Obstruction, Journal Of Pediatric Gastroenterology And Nutrition, Male, microcephaly, Mordekar S R, motor dysfunction, MPSIII, onset age, Parenteral Nutrition, Percutaneous Endoscopic Gastrostomy, peristalsis, pharmacologic intervention, Practice Guideline, Preschool Child, Priority Journal, reflux esophagitis, Retrospective Study, Rett syndrome, Sanfilippo syndrome, School Child, tone and motor problems, total parenteral nutrition, Velayudhan M, West syndrome
Prophylactic effect of L 5 hydroxytryptophan on self mutilation in the Lesch Nyhan syndrome
Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome
Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment
Gabapentin can significantly improve dystonia severity and quality of life in children
Effective treatment of spasticity using dronabinol in pediatric palliative care
A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease
Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease
Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status
Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group
Constipation in epidermolysis bullosa: successful treatment with a liquid fiber-containing formula
Tags: 1997, Adolescent Child, Atherton D, Child, Clayden G, Constipation, Constipation/co [Complications], Constipation/th [Therapy], epidermolysis bullosa, Epidermolysis Bullosa/co [Complications], Female, fiber-containing liquid formula Enrich, Food, Formulated, Haynes L, Humans, Male, Pediatric Dermatology, pharmacologic intervention, Preschool
Melatonin ineffective in neuronal ceroid lipofuscinosis patients with fragmented or normal motor activity rhythms recorded by wrist actigraphy
Tags: 0 (Antioxidants), 1999, Adolescent, Adult, Antioxidants/tu [Therapeutic Use], Child, Circadian Rhythm, Dose-Response Relationship, Drug Electrophysiology, Female, Hätönen T, Heiskala H, Humans, JL5DK93RCL (Melatonin), Kirveskari E, Laakso M L, Male, melatonin, Melatonin/tu [Therapeutic Use], Molecular Genetics and Metabolism, NCL3, Neuronal Ceroid-Lipofuscinoses/dt [Drug Therapy], pharmacologic intervention, Sainio K, Santavuori P, sleep disturbance/disorders, Sleep Wake Disorders/th [Therapy]
Effect of melatonin dosage on sleep disorder in tuberous sclerosis complex
Tags: 2005, Administration Oral, Adult, Antioxidants/pharmacology/therapeutic use, Child, Child Preschool, Cross-Over Studies, Dose-Response Relationship Drug, Double-Blind Method, Female, Hancock E, Humans, Infant, Journal of Child Neurology, Male, melatonin, Melatonin/pharmacology/therapeutic use, O'Callaghan F, Osborne J P, pharmacologic intervention, sleep disturbance/disorders, Sleep Wake Disorders/drug therapy/etiology, Treatment Outcome, Tuberous Sclerosis, Tuberous Sclerosis/complications
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
Tags: 2012, Adolescent, Allport T, Appleton R, British Medical Journal, Central Nervous System Depressants/administration & dosage/adverse effects, Central Nervous System Diseases/complications, Child, Child Preschool, Child Behavior/drug effects, Choonara I, Developmental Disabilities/complications, Dose-Response Relationship Drug, Drug Monitoring, Edmond A, Family Health, Female, Gamble C, Gringras P, Humans, Jones A P, Male, melatonin, Melatonin/administration & dosage/adverse effects, Montgomery P, pharmacologic intervention, Polysomnography/methods, Q3 conditions, Severity Of Illness Index, sleep disturbance/disorders, Sleep Wake Disorders/diagnosis/drug therapy/etiology, Sleep/drug effects, Sutcliffe A, Treatment Outcome, unspecified Q3 conditions, Whitehouse W P, Wiggs L, Williamson P R
Melatonin for treatment of sleep disorders in children with developmental disabilities
Prolonged-release melatonin for children with neurodevelopmental disorders
Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials
Tags: 1996, Adolescent, Camfield C, Camfield P, Child, Child Preschool, Dooley J, Double-Blind Method, Female, Gordon K, Humans, Intellectual Disability/complications, Journal of Child Neurology, Male, melatonin, Melatonin/therapeutic use, neurodevelopmental disorder, pharmacologic intervention, sleep disturbance/disorders, Sleep Wake Disorders/drug therapy/etiology, undefined neurodevelopmental disorders
Successful treatment of cataplexy in patients with early-infantile Niemann-Pick disease type C: use of tricyclic antidepressants
Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study
Tags: 2008, Adolescent, Adult, Aged, Braam W, Central Nervous System Depressants/adverse effects/therapeutic use, Child, Child Preschool, chromosome 18q deletion, Chronic Disease, Comorbidity, Curfs L, Didden R, Double-Blind Method, Female, Humans, Journal Of Intellectual Disability Research, Male, melatonin, Melatonin/adverse effects/therapeutic use, Mental Retardation/epidemiology/psychology, Middle Aged, MPS III, pharmacologic intervention, Q3 Scoping Review Results, Saliva, sleep disturbance/disorders, Sleep Initiation and Maintenance Disorders/drug therapy/epidemiology/psychology, Smits M, Time Factors, Treatment Outcome
Levodopa is not a useful treatment for Lesch-Nyhan disease
The use of Melatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
Tags: 2012, Appleton R E, autism spectrum disorders, Barker C, CONTROLLED-TRIAL, exogenous melatonin, Gamble C, Gringras P, handicapped-children, Health Care Sciences & Services, Health Technology Assessment, improves sleep, insomnia, Jones A P, melatonin, Montgomery P, neurodevelopmental disorders, onset, pharmacologic intervention, phase, rett-syndrome, serum melatonin, sleep disturbance/disorders, Sutcliffe A, Syndrome, Wiggs L, Williamson P R, young-adults
The effect of L 5 hydroxytryptophan on self mutilation in Lesch Nyhan disease: a negative report
Tags: 1976, Anderson L T, automutilation, behavioral problems, carbidopa, Child, Clinical Study, Clinical Trial, Controlled Study, Dancis J, Drug Therapy, Herrmann L, Human, L-5-hydroxyl-tryptophan, Lesch Nyhan syndrome, Major Clinical Study, Neuropadiatrie, pharmacologic intervention, PLACEBO, self-mutilation, Therapy